EUVIMEDEUVIMED entdecken
Crossref

Fungal Enzyme‐Responsive Hydrogel Drug Delivery Platform for Triggered Antifungal Release

Noel Vera-González, Carly Deusenbery iD, Veronica LaMastro iD, Anita Shukla iD

Advanced Healthcare Materials · 2024-12 · 13 (30)

DOI: 10.1002/adhm.202401157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 29.08.2024. Verfasst von Noel Vera-González und 3 weiteren Autor:innen. Beteiligte Einrichtung: School Of Engineering, Institute for Biology, Engineering, and Medicine, Brown University, 184 Hope Street, Providence, RI, 02912, USA. Hauptthemen laut MEDLINE: Antifungal Agents, Hydrogels, Candida albicans. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Office of Naval Research, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fungal infections can lead to debilitating consequences if they are not treated effectively. Antifungal drugs used to treat these infections can be toxic and overuse contributes to growing antifungal resistance. Candida spp., particularly C. albicans , are implicated in a majority of these infections. Virulent C. albicans produce secreted aspartic proteases (Saps) that aid in pathogen tissue invasion and proliferation at an infected site. Here, fungi‐responsive hydrogels are developed that degrade in the presence of Saps to provide a triggered release of encapsulated liposomal antifungals. The hydrogel backbone incorporates a Sap‐cleavable peptide sequence enabling Sap‐responsive degradation. Hydrogels are found to effectively degrade in the presence of Saps extracted from C. albicans . Encapsulated liposomal antifungals show similar release kinetics as hydrogel degradation products in the presence of Saps, supporting a degradation‐dependent release mechanism. Antifungal liposome‐loaded responsive hydrogels exhibit successful eradication of C. albicans cultures and remain stable in sterile murine wound fluid. Finally, no significant cytotoxicity is observed for murine fibroblast cells and red blood cells exposed to hydrogel degradation products. These fungi‐responsive hydrogels have the potential to be used for local, on‐demand delivery of antifungal drugs, for effective treatment of fungal infections while helping to limit unnecessary exposure to these therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsHydrogelsCandida albicansAnimalsMiceDrug Delivery SystemsLiposomesAspartic Acid ProteasesCandidiasis

Stichwörter der Autor:innen

Candida albicansantifungalbiomaterialsenzyme‐responsive drug deliveryhydrogels

Substanzen

Antifungal AgentsHydrogelsLiposomesAspartic Acid Proteases

Autor:innen und Institutionen

  • School Of Engineering, Institute for Biology, Engineering, and Medicine, Brown University, 184 Hope Street, Providence, RI, 02912, USA.

ORCID-Profile: Carly Deusenbery, Veronica LaMastro, Anita Shukla

Förderung

  • Office of Naval Research
  • National Science Foundation

Zitieren

APA

Vera-González, N., Deusenbery, C., LaMastro, V., & Shukla, A. (2024). Fungal Enzyme‐Responsive Hydrogel Drug Delivery Platform for Triggered Antifungal Release. Advanced Healthcare Materials, 13(30). https://doi.org/10.1002/adhm.202401157

Vancouver

Vera-González N, Deusenbery C, LaMastro V, Shukla A. Fungal Enzyme‐Responsive Hydrogel Drug Delivery Platform for Triggered Antifungal Release. Advanced Healthcare Materials. 2024;13(30). doi:10.1002/adhm.202401157

BibTeX
@article{VeraGonzlez2024,
  author = {Vera-González, Noel and Deusenbery, Carly and LaMastro, Veronica and Shukla, Anita},
  title = {Fungal Enzyme‐Responsive Hydrogel Drug Delivery Platform for Triggered Antifungal Release},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {30},
  doi = {10.1002/adhm.202401157}
}
Kostenlos starten →